Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Keely Treatment.

The Dental register·2021
Same author

Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.

The British journal of dermatology·2015
Same author

Impact of source of sulfur on ruminal hydrogen sulfide and logic for the ruminal available sulfur for reduction concept.

Journal of animal science·2013
Same author

Effect of corn bran and steep inclusion in finishing diets on diet digestibility, cattle performance, and nutrient mass balance.

Journal of animal science·2013
Same author

Ruminally undegradable protein content and digestibility for forages using the mobile bag in situ technique.

Journal of animal science·2013
Same author

Effect of feeding combinations of wet distillers grains and wet corn gluten feed to feedlot cattle.

Journal of animal science·2009
Same journal

Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Characterization of a novel α-thalassemia deletion (Dongxing deletion; --<sup>DX</sup>) by CNV-seq in a Chinese female with Hb H disease: a case report.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective study.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Relationship between major depressive disorder and venous thromboembolism: a five-ancestry genetic analysis.

Hematology (Amsterdam, Netherlands)·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.0K

The Rationale for not Routinely Purging Autologous Blood Stem Cell Grafts.

C D Buckner1, R Birch1, C H Weaver1

  • 1a Clinical Research Division of Response Oncology, Inc. , 1775 Moriah Woods Blvd., Memphis , TN 38117.

Hematology (Amsterdam, Netherlands)
|July 15, 2016
PubMed
Summary
This summary is machine-generated.

Autologous stem cell transplantation (ASCT) purging technologies aim to remove tumor cells but are not yet standard of care. Clinical use requires documented safety and efficacy from randomized trials.

Keywords:
Autologous graftCD34 selectionpurging

More Related Videos

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.5K

Related Experiment Videos

Last Updated: Mar 17, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.0K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.5K

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Autologous stem cell transplantation (ASCT) is a critical treatment modality.
  • Significant interest exists in purging tumor cells from grafts to improve ASCT outcomes.
  • Current purging technologies are widely perceived as potentially beneficial, if harmless.

Purpose of the Study:

  • To evaluate the current status and clinical applicability of tumor cell purging in ASCT.
  • To determine the criteria for adopting purging technologies in clinical practice.

Main Methods:

  • Review of over a decade of intensive research on graft purging technologies for ASCT.
  • Analysis of the limitations of in-vitro efficacy demonstrations.
  • Assessment of the potential impact of purging on graft hematologic and immunologic functions.

Main Results:

  • Despite extensive research, no current tumor cell purging technology has achieved standard of care status for ASCT.
  • In-vitro tumor cell removal does not adequately predict clinical efficacy or safety.
  • All investigated purging techniques carry a risk of adversely affecting the graft's essential functions.

Conclusions:

  • Tumor cell purging technologies are not currently recommended for routine clinical use in ASCT outside of research settings.
  • Clinical implementation requires rigorous validation through randomized clinical trials to establish safety and efficacy.
  • The potential benefits of purging must be weighed against the risks of compromising graft quality.